---
title: fastingmimicking diet development
videoId: evGFWRXEzz8
---

From: [[foundmyfitness]] <br/> 

The [[Fastingmimicking diet and longevity | fasting-mimicking diet]] (FMD) was developed to harness the benefits of dietary restriction, particularly [[Fasting and metabolic health | fasting]], while overcoming the challenges associated with traditional methods like chronic caloric restriction or water-only [[intermittent fasting | fasting]] <a class="yt-timestamp" data-t="01:00:51">[01:00:51]</a>.

## Motivation and Purpose

The primary motivation for developing the FMD stemmed from the long-term goal of achieving the benefits of caloric restriction without its inherent problems <a class="yt-timestamp" data-t="01:15:09">[01:15:09]</a>. Early research had demonstrated the beneficial effects of starving yeast and bacteria <a class="yt-timestamp" data-t="01:15:25">[01:15:25]</a>. A key insight was the differential stress resistance phenomenon: starving a system causes normal cells to become protected, while cancer cells remain sensitive to stressors <a class="yt-timestamp" data-t="01:16:01">[01:16:01]</a>.

Initial efforts to apply this understanding in cancer patients using water-only [[Fasting and cancer therapy | fasting]] revealed a significant barrier: patients' reluctance to fast <a class="yt-timestamp" data-t="01:16:13">[01:16:13]</a>. This practical challenge provided the motivation to create a "[[Fastingmimicking diet and longevity | fasting-mimicking diet]]" â€“ a diet designed to replicate the physiological effects of [[Fasting and metabolic health | fasting]] while still allowing patients to eat <a class="yt-timestamp" data-t="01:16:34">[01:16:34]</a>.

The development of the FMD was supported by funding from the National Cancer Institute and subsequently the National Institute on Aging <a class="yt-timestamp" data-t="01:16:42">[01:16:42]</a>.

## Scientific Basis and Design

The FMD's design is rooted in a deep understanding of the connection between specific nutrients and key genetic pathways involved in aging and cellular function <a class="yt-timestamp" data-t="01:16:56">[01:16:56]</a>. These include:
*   **Amino acids and TOR/IGF-1**: Proteins, especially certain amino acids like methionine and cysteine, regulate IGF-1 levels, which play an important role in aging <a class="yt-timestamp" data-t="00:09:46">[00:09:46]</a>. Limiting protein intake is crucial for lowering IGF-1 <a class="yt-timestamp" data-t="00:09:19">[00:09:19]</a>.
*   **Sugars and PKA**: Specific sugars can activate PKA <a class="yt-timestamp" data-t="01:17:05">[01:17:05]</a>. PKA is considered central, potentially handling both protein and sugar signaling pathways <a class="yt-timestamp" data-t="01:18:08">[01:18:08]</a>.
*   **Ras**: While its role in mammalian cells was less clear during initial development, Ras was also a target in the design <a class="yt-timestamp" data-t="01:17:45">[01:17:45]</a>.
*   **Insulin**: Insulin and IGF-1 are interconnected and both linked to growth hormone signaling <a class="yt-timestamp" data-t="01:19:02">[01:19:02]</a>.
*   **Metabolic Markers**: The diet was formulated to achieve metabolic shifts equivalent to water-only [[Fasting and metabolic health | fasting]], including changes in IGF-1, IGFBP-1, ketone bodies, and glucose <a class="yt-timestamp" data-t="01:17:21">[01:17:21]</a>.

The FMD aims to nourish the individual while simultaneously influencing these pathways and markers <a class="yt-timestamp" data-t="01:17:21">[01:17:21]</a>.

## Unique Features and Benefits

The FMD differentiates itself from other [[different fasting methods and their effects | fasting methods]] and caloric restriction in several key ways:

*   **Targeted Effects on Biomarkers**: In healthy individuals with already good biomarker levels (e.g., low blood pressure, low fasting glucose), the FMD does not drive these markers even lower <a class="yt-timestamp" data-t="01:31:36">[01:31:36]</a>. However, for those with elevated markers (e.g., high cholesterol, triglycerides, IGF-1, fasting glucose, blood pressure, systemic inflammation/CRP), the FMD helps to normalize them <a class="yt-timestamp" data-t="01:33:05">[01:33:05]</a>. This suggests a "resetting" of the system to its functional ideal state <a class="yt-timestamp" data-t="01:33:50">[01:33:50]</a>.

*   **Metabolic Flexibility and Weight Loss**: Unlike some "yo-yo" diets that can slow metabolism, the FMD's short duration (typically five days) prevents the body from switching to a chronically slower metabolism <a class="yt-timestamp" data-t="01:40:11">[01:40:11]</a>. It promotes metabolic flexibility, allowing the body to efficiently switch between using glucose and fatty acids for energy <a class="yt-timestamp" data-t="01:41:20">[01:41:20]</a>. Studies in mice show that after FMD, they eat the same total calories per month but lose weight, suggesting a sustained fat-burning mode <a class="yt-timestamp" data-t="01:42:01">[01:42:01]</a>.

*   **Preservation of Lean Body Mass**: Most diets result in the loss of fat, water, and muscle <a class="yt-timestamp" data-t="01:42:55">[01:42:55]</a>. The FMD temporarily reduces muscle mass and preferentially targets visceral (abdominal) fat while sparing subcutaneous fat <a class="yt-timestamp" data-t="01:43:14">[01:43:14]</a>. Critically, during the refeeding phase, muscle mass is rebuilt, leading to maintenance of normal lean body mass or even an increase in relative lean body mass <a class="yt-timestamp" data-t="01:43:30">[01:43:30]</a>. This is a significant advantage for [[Fastingmimicking diet and longevity | longevity]] <a class="yt-timestamp" data-t="01:44:15">[01:44:15]</a>.

*   **Regenerative and Rejuvenating Effects**:
    *   **Organ Shrinking and Regrowth**: During [[Fasting and caloric restriction mimetics | fasting]], organs temporarily shrink, then return to normal size during refeeding <a class="yt-timestamp" data-t="01:45:08">[01:45:08]</a>.
    *   **Preferential Clearing of Damaged Cells**: The FMD promotes the killing of damaged cells (apoptosis), including those involved in autoimmune diseases, and the depletion of intracellular components through autophagy <a class="yt-timestamp" data-t="01:45:33">[01:45:33]</a>.
    *   **[[Fasting and stem cell regeneration | Stem Cell Activation]] and Regeneration**: A crucial aspect of FMD is the activation of [[Fasting and stem cell regeneration | stem cells]] during the [[Fasting and caloric restriction mimetics | fasting]] phase, followed by their proliferation and differentiation into healthy cells during the refeeding phase <a class="yt-timestamp" data-t="01:46:11">[01:46:11]</a>. This "destruction" followed by "reconstruction" phase is a key distinction from chronic caloric restriction, which lacks the refeeding component <a class="yt-timestamp" data-t="01:47:13">[01:47:13]</a>. This process is posited as an evolved "auto-repair mode" for the body's internal systems <a class="yt-timestamp" data-t="01:49:18">[01:49:18]</a>.

*   **Psychological Benefits**: The temporary nature of the 5-day FMD, followed by a return to a regular diet for the rest of the month, is psychologically beneficial for compliance compared to continuous dietary restrictions <a class="yt-timestamp" data-t="01:42:42">[01:42:42]</a>.

## Clinical Application and Future Directions

Over 25,000 individuals have used the FMD product (Prolon) that was clinically tested <a class="yt-timestamp" data-t="01:36:44">[01:36:44]</a>. While formal FDA approval involves a long and expensive process, clinical trials have shown the FMD to be safe in cancer treatment, though food aversion in patients on chemotherapy has been a challenge <a class="yt-timestamp" data-t="02:06:06">[02:06:06]</a>.

The recommended frequency of FMD cycles varies based on an individual's health status and lifestyle, ranging from once or twice a year for very healthy individuals to once a month for those with obesity or multiple disease risk factors <a class="yt-timestamp" data-t="01:35:50">[01:35:50]</a>.

Research continues to explore the FMD's potential as a complementary metabolic intervention for various diseases, including diabetes (type 1 and 2), autoimmune diseases, Alzheimer's, neurodegeneration, and cardiovascular disease <a class="yt-timestamp" data-t="01:00:56">[01:00:56]</a>. Future studies will delve deeper into stem cell activation, including muscle biopsies in athletes to assess satellite cells <a class="yt-timestamp" data-t="01:50:51">[01:50:51]</a>.